233
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Perindopril in Breast Milk and Determination of Breastfed Infant Exposure: A Prospective Observational Study

, ORCID Icon, , ORCID Icon, , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 961-967 | Published online: 02 Mar 2020

References

  • GartnerLM, MortonJ, LawrenceRA, et al. Breastfeeding and the use of human milk. Pediatrics. 2005;115(2):496–506.15687461
  • HoddinottP, TappinD, WrightC, Breast feeding. BMJ. 2008;336(7649):881–887. doi:10.1136/bmj.39521.566296.BE18420694
  • GenevaSW. The Optimal Duration of Exclusive Breastfeeding. A Systematic Review. Geneva: WHO; 2001 Available from: https://www.who.int/nutrition/publications/infantfeeding/WHO_NHD_01.09/en/. Accessed 210, 2020.
  • NHMRC.Infant Feeding Guidelines: Information for Healthcare Workers. NHMRC; 2012 Available from: https://nhmrc.gov.au/about-us/publications/infant-feeding-guidelines-information-health-workers. Accessed 210, 2020.
  • PearlsteinTB, ZlotnickC, BattleCL, et al. Patient choice of treatment for postpartum depression: a pilot study. Arch Womens Ment Health. 2006;9(6):303–308.16932988
  • Program NH. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):s1–s22. doi:10.1067/mob.2000.107928
  • Nelson-PiercyC. Handbook of Obstetric Medicine. CRC press; 2015 4, 8.
  • DunietzGL, StrutzKL, HolzmanC, et al. Moderately elevated blood pressure during pregnancy and odds of hypertension later in life: the POUCHmoms longitudinal study. BJOG. 2017;124(10):1606–1613.28074637
  • VeerbeekJH, HermesW, BreimerAY, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015;65(3):600–606.25561694
  • EngelandA, BjørgeT, KlungsøyrK, SkjærvenR, SkurtveitS, FuruK, Preeclampsia in pregnancy and later use of antihypertensive drugs. Eur J Epidemiol. 2015;30(6):501–508. doi:10.1007/s10654-015-0018-525784365
  • DiNicolantonioJJ, LavieCJ, O’KeefeJH, Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. Postgrad Med. 2013;125(4):154–168. doi:10.3810/pgm.2013.07.2687
  • FerrariR, PasanisiG, NotarstefanoP, CampoG, GardiniE, CeconiC. Specific properties and effect of perindopril in controlling the renin–angiotensin system. Am J Hypertens. 2005;18(S5):142S–54S.16125051
  • Perindopril. Micromedex Solutions. IBM Watson Available from: https://www.micromedexsolutions.com/home/dispatch/ssl/true. Accessed 119, 2019.
  • LwinEM, GerberC, SongY, et al. A new LC-MS/MS bioanalytical method for perindopril and perindoprilat in human plasma and milk. Anal Bioanal Chem. 2017;409(26):6141–6148.28842738
  • US Department of Health and Human Services (US DHHS), Food and Drug Administration (FDA), Centre for Drug Evaluation of Research (CDER), Centre for Biological Evaluation and research (CBER). Guidance for Industry; Clinical Lactation Studies – Study Design, Data Analysis, and Recommendations for Labelling. Maryland, USA: Food and Drug Administration; 2005.
  • HaleTW, RoweHE. Medications & Mothers’ Milk. Springer.  2019.
  • AndersonPO, What do all the numbers mean? Breastfeed Med. 2016;11(6):277–279. doi:10.1089/bfm.2016.007627269212
  • IlettKF, KristensenJH, Wojnar-HortonRE, BeggEJ, Drug distribution in human milk. Aust Prescr. 1997;20(2):35–40. doi:10.18773/austprescr.1997.032
  • Lactmed. Available from: https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm. Accessed 210, 2020.
  • SchaeferC, PetersPW, MillerRK, editors. Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment. Academic Press; 2014 9, 17.
  • BriggsGG, FreemanRK, YaffeSJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 11th ed. Lippincott Williams & Wilkins; 2017.
  • e-lactancia. Available from: http://www.e-lactancia.org. Accessed 210, 2020.
  • SennesaelJ, AliA, SwenyP, et al. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure. Br J Clin Pharmacol. 1992;33:93–99. doi:10.1111/bcp.1992.33.issue-11311597
  • RedmanCW, KellyJG, CooperWD, The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol. 1990;38(1):99. doi:10.1007/BF003148152158450
  • BeggEJ, RobsonRA, GardinerSJ, et al. Quinapril and its metabolite quinaprilat in human milk. Br J Clin Pharmacol. 2001;51(5):478–481.11422007
  • DevlinRG, FleissPM, Captopril in human blood and breast milk. J Clin Pharmacol. 1981;21(2–3):110–113. doi:10.1002/jcph.1981.21.issue-2-37014657
  • BeardmoreKS, MorrisJM, GalleryED, Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy. 2002;21(1):85–95. doi:10.1081/PRG-12000291212044345
  • ShannonME, MalechaSE, ChaAJ, Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) and lactation: an update. J Hum Lact. 2000;16(2):152–155. doi:10.1177/08903344000160021311153347